<DOC>
	<DOCNO>NCT00493480</DOCNO>
	<brief_summary>Patients large esophageal varix yet experience bleeding , normally treat propranolol , beta block agent reduces portal pressure thereby diminish risk bleeding . 20-40 % patient respond treatment discontinue treatment side effect . The aim study evaluate carvedilol ( combine alfa -beta blocker ) good efficacy safety propranolol lower portal pressure patient cirrhosis .</brief_summary>
	<brief_title>Danish Carvedilol Study Portal Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<criteria>Cirrhosis HVPG &gt; 12 mmHg Respiratory disease contradict endoscopy Hepatic encephalopathy Hepatorenal syndrome COPD Asthma Treatment vasoactive drug within 1 week inclusion Heart disease contradict treatment betablocking agent IDDM Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>